Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Johnson L. Thistle"'
Publikováno v:
Canadian Journal of Gastroenterology, Vol 4, Iss 9, Pp 624-627 (1990)
Radiolucent cholesterol gallstones can be dissolved rapidly by methyl terc-buryl ether (MTBE) introduced directly into the gallbladder. Percutaneous transhepatic catheter placement is a well established interventional radiology procedure and is the p
Externí odkaz:
https://doaj.org/article/2ae778352dd34a9a99d62ed07682c0fb
Autor:
Johnson L Thistle
Publikováno v:
Canadian Journal of Gastroenterology, Vol 4, Iss 9, Pp 621-623 (1990)
Chenodiol is noninvasive, safe and moderately expensive. Because of diarrhea, the need for aminotransferase monitoring, the long duration of therapy required, and the minority of patients who are appropriate candidates, it has had limited use. Ursodi
Externí odkaz:
https://doaj.org/article/86e55dd8a4664d1a93f3ae65155b2257
Autor:
Johnson L. Thistle, Yvonne Romero, Nancy N. Diehl, Julie A. Simonson, George F. Longstreth, Alan R. Zinsmeister, Amindra S. Arora, William S. Harmsen
Publikováno v:
Clinical Gastroenterology and Hepatology. 9:891-896
Upper abdominal pain (UAP) in patients with gallstones is often treated by cholecystectomy but it frequently persists. We aimed to identify symptoms associated with relief.We followed 1008 patients who received cholecystectomy for gallstones and UAP
Autor:
George F. Longstreth, Carol T. Van Dyke, G. Richard Locke, W. Scott Harmsen, Amindra S. Arora, Claudia O. Zein, Cathy D. Schleck, Yvonne Romero, Johnson L. Thistle, Alan R. Zinsmeister, Darrell S. Pardi
Publikováno v:
American Journal of Gastroenterology. 98:1042-1051
Objectives Gallstone disease is common and causes high health care costs, but a measure of symptomatic biliary disease for outcome studies is lacking. We aimed to develop a reproducible, valid, discriminative, disease-specific measure of biliary symp
Autor:
Keith D. Lindor, Johnson L. Thistle, Jessica Henry, Terry M. Therneau, Darius Sorbi, Douglas B. McGill
Publikováno v:
The American Journal of Gastroenterology. 95:3206-3210
The role of liver biopsy in the management of patients with nonspecific chronic liver enzyme abnormalities is not well established. The aim of this study is to determine whether liver histology changes the clinical impression formed before liver biop
Autor:
Johnson L. Thistle
Publikováno v:
World Journal of Surgery. 22:1114-1118
Secondary duct stones are usually detected and easily removed at the time of cholecystectomy either during surgery or endoscopically before or after the operation. Primary duct stone diseases, although much less common, are often a greater therapeuti
Autor:
Mark Topazian, Jeff L. Fidler, Douglas A. Collins, Kiaran P. McGee, John M. Knudsen, Johnson L. Thistle, Brian D. Lahr
Publikováno v:
AJR. American journal of roentgenology. 201(2)
The objectives of our study were to assess the feasibility of dynamic CT and MR cholangiography during gallbladder stimulation, to compare CT and MR cholangiography with biliary scintigraphy, and to identify morphologic differences between patients w
Autor:
Gerald R. May, Joseph W. Segura, Johnson L. Thistle, David M. Nagorney, David E. Patterson, Craig J. Peine
Publikováno v:
Mayo Clinic Proceedings. 65:1564-1569
Passage of stone fragments after extracorporeal shock wave lithotripsy (ESWL) of gallstones has resulted in biliary colic, duct obstruction, and pancreatitis in some patients. Rapid dissolution of these fragments with methyl tert-butyl ether (MTBE) m
Publikováno v:
Canadian Journal of Gastroenterology, Vol 4, Iss 9, Pp 624-627 (1990)
Radiolucent cholesterol gallstones can be dissolved rapidly by methyl terc-buryl ether (MTBE) introduced directly into the gallbladder. Percutaneous transhepatic catheter placement is a well established interventional radiology procedure and is the p
Autor:
David L. Earnest, Dongham Luo, Victor Shi, Angeli Dogra, Johnson L. Thistle, Robert S. Fisher, Christoph Beglinger, Peter Rueegg, James Novick, William D. Chey, Anthony Lembo, Patrick O'Kane
Publikováno v:
The American journal of gastroenterology. 99(7)
OBJECTIVE: Tegaserod is a 5-HT4 receptor partial agonist that increases peristaltic activity of the intestinal tract. It is approved for the treatment of patients with irritable bowel syndrome with constipation (IBS-C). IBS is a chronic gastrointesti